Company Profile

Bernard Technologies Inc
Profile last edited on: 12/14/06      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
----
First Award
2000
Latest Award
2000
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

919 N Michigan Avenue Suite 1710
Chicago, IL 60611
   (312) 337-7007
   N/A
   www.bernardtechnologies.com
Location: Multiple
Congr. District: 07
County: Cook

Public Profile

Bernard Technologies, Inc., (BTI) produces a broad range of controlled release, active packaging components that function as microbiocides and odor neutralizing products for healthcare, food, agricultural, medical, consumer, and industrial products & markets. Bernàrd Technologies, Inc., (BTI) has an Asia-Pacific Sales & Development Office in the Republic of Singapore, produces a broad range of patented controlled release, active packaging & products that function as microbiocides and odor neutralizing products. BTI has developed two proprietary, controlled release technologies called Microsphère® and Microlìte® that focus on preventing and eliminating biological contamination. Both the Microsphère® and Microlìte® patented sustained release systems, are innovative technologies enabling the creation of an active Microatmosphère® environment that inhibits the growth of microorganisms and actively neutralizes undesirable odors. The active Microatmosphère® is formed by the generation of a highly effective broad spectrum antimicrobial compound that is often used for disinfecting and sterilizing materials in food and medical applications. The unique Microatmosphère® is a controlled vapor-phase system that controls biological contamination without requiring direct surface contact. The product being protected is effectively sealed in a “vapor of freshness.” The controlled release feature allows the different forms of the Microsphère® and Microlìte® products to remain active for specific ext

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
15-19

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2000 1 NIH $140,611
Project Title: Antimicrobial Coating for Implantable Devices

Key People / Management

  Sumner Barenberg -- President

  Stuart Williams

Company News

There are no news available.